Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Serum cytokine levels early post-allogeneic haematopoietic stem cell transplant are predictors of GvHD and survival

Conference paper

Danby R. et al, (2013), BONE MARROW TRANSPLANTATION, 48, S412 - S412

Treg GMP isolation for clinical trial in haematopoietic stem cell transplantation: lessons and experience

Conference paper

Zhang W. et al, (2011), BRITISH JOURNAL OF HAEMATOLOGY, 153, 68 - 68

Production of TNF alpha discriminates activated human Th cells from Treg cells

Conference paper

Zhang W. et al, (2011), BRITISH JOURNAL OF HAEMATOLOGY, 153, 68 - 68

In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells.

Journal article

Nadig SN. et al, (2010), Nat Med, 16, 809 - 813

Ex vivo expansion of regulatory T-cells is enhanced by the inhibition of Fas-induced apoptosis

Conference paper

Zhang W. et al, (2010), BONE MARROW TRANSPLANTATION, 45, S324 - S324

Ex vivo expanded human treg inhibit the development of transplant arteriosclerosis in a humanized in vivo model

Conference paper

Nadig SN. et al, (2008), JOURNAL OF HEART AND LUNG TRANSPLANTATION, 27, S179 - S179

Use of ELISPOTS to monitor cloning of AChR-specific T-cells from myasthenia gravis patients

Conference paper

Zhang W. et al, (2004), JOURNAL OF NEUROIMMUNOLOGY, 154, 150 - 150

Circulating regulatory anti-T cell receptor antibodies in patients with myasthenia gravis.

Journal article

Jambou F. et al, (2003), J Clin Invest, 112, 265 - 274

Scenarios for autoimmunization of T and B cells in myasthenia gravis

Journal article

Shiono H. et al, (2003), MYASTHENIA GRAVIS AND RELATED DISORDERS, 998, 237 - 256